Enterprise Financial Services Corp (EFSC)’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-410	Closed	-$21K	–	360
2021 Q4	$21K	Hold	410	–	–	﹤0.01%	305
2021 Q3	$26K	Hold	410	–	–	﹤0.01%	315
2021 Q2	$30K	Hold	410	–	–	﹤0.01%	502
2021 Q1	$30K	Hold	410	–	–	0.01%	512
2020 Q4	$30K	Hold	410	–	–	0.01%	485
2020 Q3	$22K	Hold	410	–	–	﹤0.01%	541
2020 Q2	$27K	Hold	410	–	–	0.01%	491
2020 Q1	$25K	Hold	410	–	–	0.01%	460
2019 Q4	$36K	Hold	410	–	–	0.01%	476
2019 Q3	$31K	Hold	410	–	–	0.01%	480
2019 Q2	$35K	Hold	410	–	–	0.01%	481
2019 Q1	$44K	Buy	+410	New	+$40.8K	0.01%	431
2018 Q1	–	Sell	-44	Closed	-$5K	–	963
2017 Q4	$5K	Hold	44	–	–	﹤0.01%	709
2017 Q3	$5K	Hold	44	–	–	﹤0.01%	719
2017 Q2	$5K	Buy	44 +40	+1,000%	+$4.52K	﹤0.01%	720
2017 Q1	$0	Sell	4 -26	-87%	-$2.88K	﹤0.01%	1106
2016 Q4	$3K	Buy	+30	New	+$3.14K	﹤0.01%	877

Other funds holding TARO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s TARO Position: Q1 2022 in Review

Enterprise Financial Services Corp (EFSC) sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2022, closing a stake of 410 shares — an estimated $21K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in TARO in Q4 2016 and held it in 17 quarters. The position peaked at $44K in Q1 2019. 69 funds tracked by Wall St. Rank hold TARO as of Q1 2022.

Enterprise Financial Services Corp (EFSC) reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2022 after selling out during the quarter.
Enterprise Financial Services Corp (EFSC) sold 410 Taro Pharmaceutical Industries Ltd. shares in Q1 2022, an estimated $21K.
Enterprise Financial Services Corp (EFSC) first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2016 and held it in 17 quarters.
Enterprise Financial Services Corp (EFSC)'s Taro Pharmaceutical Industries Ltd. position peaked at $44K in Q1 2019.
69 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2022.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q1 2022, filed 16 May 2022.